Diffuse pontine gliomas in children: changing strategies, changing results? A mono-institutional 20-year experience.

被引：58

作者：

Massimino M. ^{[1
]}

Spreafico F. ^{[1
]}

Biassoni V. ^{[1
]}

Simonetti F. ^{[1
]}

Riva D. ^{[1
]}

Trecate G. ^{[1
]}

Giombini S. ^{[1
]}

Poggi G. ^{[1
]}

Pecori E. ^{[1
]}

Pignoli E. ^{[1
]}

Casanova M. ^{[1
]}

Ferrari A. ^{[1
]}

Meazza C. ^{[1
]}

Luksch R. ^{[1
]}

Terenziani M. ^{[1
]}

Cefalo G. ^{[1
]}

Podda M. ^{[1
]}

Polastri D. ^{[1
]}

Clerici C.A. ^{[1
]}

Fossati-Bellani F. ^{[1
]}

Gandola L. ^{[1
]}

机构：

[1] Fondazione IRRCCS Istituto Nazionale Tumori, Pediatric Oncology Unit, Via Venezian 1, Milan

来源：

Journal of Neuro-Oncology | 2008年 / 87卷 / 3期

关键词：

Diffuse pontine glioma; Concomitant chemo–radiotherapy; Innovative therapies;

D O I：

10.1007/s11060-008-9525-5

中图分类号：

学科分类号：

摘要：

Patients with diffuse pontine gliomas have a median survival of less than one year and represent a challenge for pediatric oncologists, prompting them to attempt experimental therapies. From 1987 to 2005, 62 children with diffuse pontine glioma, not amenable to curative surgery, were treated according to four successive pilot protocols: (1) concomitant chemo-radiotherapy (etoposide, cytarabine, ifosfamide, cisplatin, and dactinomycin); (2) intensive high-dose courses chemotherapy (cisplatin/etoposide, cyclophosphamide/vincristine/methotrexate) and a subsequent course of myeloablative thiotepa followed by radiation and maintenance chemotherapy; (3) cisplatin/etoposide followed by isotretinoin before, during and after focal irradiation; and (4) iv vinorelbine before, during, and after irradiation. Considering all patients, 77% experienced a transient response to treatment, always detectable after radiotherapy. The progression-free survival (PFS) rate was 25 +/- 6% at one year, median PFS was seven months; overall survival (OS) was 45 +/- 6%, median OS was eleven months: no statistical differences in the four studies in terms of outcome were detected. Despite improved diagnostic, therapeutic, and supportive tools in pediatric neuro-oncology, little has been achieved for patients with diffuse pontine tumors.

引用

页码：355 / 361

页数：6

共 90 条

[1]

Albright AL(1999)Magnetic resonance scan should replace biopsies for the diagnosis of diffuse brain stem gliomas: a report from the Children’s Cancer Group Neurosurgery 33 1026-1029

[2]

Packer RJ(1991)Current trends in the management of brainstem tumors in childhood J Neurosci Nurs 23 356-362

[3]

Zimmerman R(2001)Outcome and long-term side effects after synchronous radiochemotherapy for childhood brain stem gliomas Pediatr Neurosurg 35 173-180

[4]

Shiminski-Maher T(2007)Treatment of newly diagnosed diffuse brain stem gliomas in children: in search of the holy grail Expert Rev Anticancer Ther 7 663-674

[5]

Abbot R(2006)Diffuse brainstem glioma in children: critical review of clinical trials Lancet Oncol 7 241-248

[6]

Wisoff JH(2000)Concomitant chemoradiotherapy for childhood poor-prognosis gliomas Med Pediatr Oncol 34 147-150

[7]

Epstein FJ(2005)Sequential chemotherapy, high-dose thiotepa, circulating progenitor cell rescue, and radiotherapy for childhood high-grade glioma Neuro Oncol 7 41-48

[8]

Benesch M(1958)Non-parametric estimation from incomplete observation J Am Stat Assoc 53 457-481

[9]

Lackner H(1972)Asymptomatically efficient rank invariant test procedures J R Stat Soc [A] 135 185-207

[10]

Moser A(2006)Transitory, spontaneously recovering, peripheral facial nerve palsy after vinorelbine administration Neurol Sci 27 110-113

← 1 2 3 4 5 6 7 8 9 →